Cryo-Cell International, Inc.CCELNYSE
Loading
Operating Cash Flow Growth Under PressureDecelerating
Percentile Rank23
Studio
Year-over-Year Change

Year-over-year operating cash flow growth rate

Percentile
P23
Within normal range
vs 5Y Ago
-1.1x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
PeriodValue
Q4 2025-49.51%
Q3 2025258.79%
Q2 2025-25.89%
Q1 2025-55.77%
Q4 2024-11.50%
Q3 202437.43%
Q2 2024596.96%
Q1 2024-110.67%
Q4 202372.17%
Q3 2023-2.35%
Q2 202321.00%
Q1 2023-32.34%
Q4 2022-9.64%
Q3 202238.09%
Q2 202229.23%
Q1 2022-9.64%
Q4 2021-19.03%
Q3 202133.98%
Q2 2021-42.26%
Q1 2021-10.57%
Q4 202045.06%
Q3 2020149.59%
Q2 2020-68.57%
Q1 2020118.18%
Q4 2019-56.85%
Q3 2019397.08%
Q2 2019-68.72%
Q1 2019111.72%
Q4 2018-69.48%
Q3 20188533.39%
Q2 2018-98.11%
Q1 2018-19.88%
Q4 201772.51%
Q3 2017-37.34%
Q2 2017355.30%
Q1 2017-83.26%
Q4 2016137.30%
Q3 2016-13.14%
Q2 20161126.04%
Q1 2016-94.90%